Hydrogen Water and Lung Health: What Recent Research Suggests

Posted on June 11, 2026

The most rigorous human study of hydrogen and the lungs didn't ask anyone to drink a glass of water. It asked them to breathe. In a ten-center, double-blind, randomized trial of patients hospitalized with a flare-up of chronic obstructive pulmonary disease, researchers piped a hydrogen-oxygen mixture into the air some patients inhaled — and tracked, day by day, whether their breathlessness, coughing, and sputum eased faster than for the patients breathing oxygen alone. That trial, and the run of lung-focused studies around it, is why "hydrogen water lung health" has quietly become one of the more interesting search terms in the whole hydrogen space.

It's also a topic that rewards careful reading. The lung research leans heavily on inhaled hydrogen rather than hydrogen-rich water, the strongest human data sits in serious clinical settings, and the mechanism researchers keep pointing to is the same one that started this entire field back in 2007. So let's walk through what the studies actually report and what any of it means for a person filling a glass at their kitchen counter.

Why researchers started pointing hydrogen at the lungs

The lungs are an oxidative battlefield. Every breath delivers oxygen, and oxygen metabolism generates reactive oxygen species as a byproduct — the same reactive molecules implicated in airway inflammation, tissue damage, and the slow decline seen in chronic lung disease. Add cigarette smoke, air pollution, or infection, and that oxidative load climbs further. So when a small gas molecule showed up in the literature with a reputation for selectively neutralizing the most damaging reactive oxygen species, lung researchers took notice.

Molecular hydrogen is about as small as a molecule gets. According to research retrieved from PubMed, that tiny size lets it diffuse across cell membranes and reach compartments many antioxidants struggle to access. In the lungs — an organ defined by gas exchange — a therapeutic gas has an unusually direct route to the tissue. That structural logic, more than any single result, is what put pulmonary function on the hydrogen research map.

What molecular hydrogen actually is

Before the lung studies make sense, the basics help. Hydrogen water is ordinary water with extra molecular hydrogen (H₂) gas dissolved into it. Hydrogen inhalation delivers the same gas directly to the airways, usually as a hydrogen-oxygen blend. Both methods are trying to get the same molecule into the body — they just take different roads.

The 2007 finding everything traces back to

Ohsawa and colleagues reported in Nature Medicine in 2007 that molecular hydrogen appeared to act as a selective antioxidant, targeting hydroxyl radicals and peroxynitrite — two of the most reactive and damaging oxygen species — while largely leaving beneficial signaling molecules alone. According to PubMed, that paper has anchored nearly every hydrogen study since, including the lung work. The researchers were careful in their framing, and so are we: this was a mechanism observed in a controlled model, not a promise about anyone's health.

Why "selective" is the word that matters

Most antioxidants are blunt instruments. They mop up reactive species broadly, including the ones your body uses on purpose for cell signaling and adaptation. The selectivity Ohsawa's team described is what made hydrogen interesting to lung researchers, who don't want to flatten every oxidative signal in an organ that depends on finely tuned redox balance.

The human COPD trial that put hydrogen and the lungs on the map

Here is the study that anchors the human side of this topic. Zheng and colleagues published a multicenter, randomized, double-blind, parallel-group controlled trial in Respiratory Research in 2021, led out of the State Key Laboratory of Respiratory Disease in Guangzhou. The trial enrolled patients hospitalized with an acute exacerbation of chronic obstructive pulmonary disease — a serious, symptom-heavy flare — and a Breathlessness, Cough, and Sputum Scale (BCSS) score of at least 6. Patients were randomly assigned to inhale either a hydrogen-oxygen mixture or oxygen alone.

What the COPD trial measured

The primary endpoint was the change in that BCSS symptom score at day 7. According to the data reported on PubMed, the hydrogen-oxygen group improved by 5.3 points versus 2.4 points in the oxygen-only group — a difference the authors stated met their pre-defined criteria for superiority. The advantage showed up consistently from day 2 onward, not just at the finish line. Cough Assessment Test scores dropped further in the hydrogen-oxygen group as well. The researchers did note that pulmonary function, arterial blood gas, and oxygen saturation measures did not differ significantly between the two groups — an honest detail worth carrying forward.

Why a cough-and-breathlessness score is a big deal

Symptom burden is what a patient actually feels. A faster drop in breathlessness, coughing, and sputum is the difference between a miserable week and a tolerable one. That a change in the inhaled gas mixture moved that needle, in a blinded trial across ten hospitals, is the kind of result that pushes a field forward.

Hydrogen and COVID-19: the dyspnea signal

The same Guangzhou research group, with senior author Nan-Shan Zhong, also reported on hydrogen during the early pandemic.

An open-label result, read with care

Guan and colleagues described, in the Journal of Thoracic Disease in 2020, a multicenter, open-label clinical trial in which hydrogen-oxygen mixed-gas inhalation was associated with improved disease severity and reduced dyspnea — shortness of breath — in patients with coronavirus disease 2019. According to PubMed, it was an open-label design rather than a blinded one, which the authors acknowledge tempers how much weight it carries. Still, it added a second respiratory dataset from a serious clinical context. Since then, researchers have kept following that thread past the acute phase, and a growing body of hydrogen research in people recovering from a viral illness has extended the picture from active infection into the recovery period that follows it.

What a 2026 review of hydrogen and COPD concluded

The most recent piece in this story landed in May 2026. Chuang, Tseng, and Chen published a narrative review in Open Medicine focused specifically on hydrogen therapy for COPD, with an emphasis on aging populations where oxidative stress and chronic inflammation run high. They applied a structured review framework and found three studies meeting their inclusion criteria — one animal experiment, one prospective clinical study, and one randomized controlled trial.

Across those studies, the reviewers reported that hydrogen administration — by inhalation or hydrogen-rich water — was associated with lower inflammatory cytokines (IL-1β, IL-6, TNF-α), reduced oxidative markers (8-OHdG), and lower senescence indicators (p16, p21, β-galactosidase). On the clinical side, they noted changes in arterial blood gases, acid-base balance, and exercise tolerance among elderly COPD patients. Their own stated conclusion was measured: the antioxidative, anti-inflammatory, and anti-senescence effects reported across preclinical and clinical settings warrant larger, longer trials to confirm efficacy and clarify dosing. That's the honest shape of this field — three included studies, and still building.

Airway inflammation and asthma: the preclinical picture

Asthma is fundamentally an airway-inflammation disease, which makes it a natural target for a molecule studied for anti-inflammatory behavior. He and colleagues published a 2024 study in Antioxidants using an ovalbumin-induced asthma model in mice. The animals were sensitized to provoke airway inflammation, then a subset inhaled 3% hydrogen gas.

The IgE and cytokine findings

The researchers reported that inhaled hydrogen significantly reduced inflammatory cell infiltration in the airways, lowered pro-inflammatory cytokine expression, and dialed down oxidative-stress markers while raising antioxidant enzyme activity. One detail stood out: the mice that inhaled hydrogen also showed lower serum immunoglobulin E (IgE), a central marker of allergic inflammation. It's a mouse model, not a human asthma trial — but it's a clean mechanistic signal in exactly the tissue this article is about.

Acute lung injury: hydrogen in the hardest models

Some of the most striking lung findings come from acute-injury models, where researchers deliberately damage lung tissue and then test whether hydrogen blunts the response. These are severe, controlled experiments. They tell us about mechanism, not about a glass of water with breakfast.

Blunt chest trauma

Ageta and colleagues reported in Surgery in 2023 that hydrogen inhalation attenuated lung contusion after blunt chest trauma in mice. The animals breathing 1.3% hydrogen showed less perivascular and intra-alveolar hemorrhage, reduced leukocyte infiltration, lower inflammatory cytokine messenger RNA, and improved oxygenation compared with injured animals breathing air alone — with the difference visible on CT imaging.

Sepsis-related lung injury

Wang and colleagues, in Materials Today Bio in 2024, explored hydrogen gas against sepsis-related acute lung injury in mice, reporting reduced oxidative stress and inflammation in lung cells. Separately, Liu and colleagues reported in BMC Chemistry in 2025 that inhaled hydrogen reduced traumatic brain injury-induced lung injury in mice by inhibiting NLRP3 inflammasome activation. Different insults, same recurring theme: less inflammation, less oxidative damage, better tissue protection.

The gas-signaling lens

Hydrogen doesn't operate in isolation. Jiang and colleagues, in a 2023 review in Antioxidants & Redox Signaling, placed hydrogen gas alongside nitric oxide, carbon monoxide, and hydrogen sulfide as small gas molecules with defined roles in respiratory biology — relevant, the authors note, across asthma, COPD, and lung infection. Reading hydrogen as one member of a broader "gasotransmitter" family is part of why respiratory specialists keep returning to it.

The mechanism researchers keep returning to

Strip away the disease labels and one thread runs through the entire lung literature: oxidative stress and inflammation. The COPD trial, the asthma model, the acute-injury studies, the 2026 review — they all describe hydrogen behaving as a selective antioxidant and an anti-inflammatory agent, exactly the profile Ohsawa's team first sketched in 2007. May decrease oxidative stress is the cautious, accurate way to say it. The studies don't claim hydrogen rebuilds lungs. They describe it lowering the oxidative and inflammatory load lungs constantly manage.

What the broader clinical record looks like

Zooming out helps.

81 trials and counting

Johnsen and colleagues catalogued the human evidence in a 2023 review in Molecules, identifying 81 registered clinical trials and 64 published human studies across a wide range of indications — cardiovascular, respiratory, neurological, and more. Respiratory disease was among the areas with positive signals. No single review settles a field, and the authors were clear that hydrogen's story as a potential therapeutic is still being written. The sheer volume of registered human work is a sign that serious clinical researchers are not treating this as fringe.

Is hydrogen water the same as hydrogen inhalation?

This is the question the lung research forces you to confront. Most of the strongest pulmonary data — the COPD trial, the COVID-19 trial, the asthma and acute-injury models — used inhaled hydrogen, not hydrogen-rich water. The two share a molecule. They don't deliver identical doses to the same tissues.

Drinking versus inhaling

Inhalation routes hydrogen straight to the airways and can deliver larger total amounts of gas. Drinking hydrogen-rich water delivers a smaller, transient dose that's absorbed and distributed through the bloodstream. Both have been studied; they aren't interchangeable, and honest content shouldn't pretend they are. For anyone reading the lung research, it is worth noticing how much of it rests on inhalation rather than drinking water.

The safety side of the picture

One reason researchers keep running these trials: hydrogen water is considered generally safe.

A reassuring safety record

Across the human studies catalogued to date, hydrogen has shown an acceptable safety and tolerability profile, and molecular hydrogen holds FDA GRAS (Generally Recognized As Safe) status for its uses in food. In the COPD trial itself, adverse events were actually reported slightly less often in the hydrogen-oxygen group than in the oxygen-only group, and no deaths or equipment failures occurred during the study period. A strong safety record is part of why this research keeps attracting investment — it lowers the barrier to running the next, larger trial.

For more on the everyday side, our guide on what hydrogen water routines actually look like covers morning, pre-workout, and evening use, and the comparison of inhalation and drinking as delivery methods goes deeper on the exact distinction the lung research keeps surfacing. If inflammation is your angle of interest, the research roundup on hydrogen water and inflammation connects directly to the mechanism running through every study above. And since the asthma research above kept surfacing allergic markers like IgE, our look at what the research suggests about hydrogen water and allergies follows that same thread into allergic rhinitis and the skin.

Where the lung research stands today

So what's the honest summary? The strongest human lung evidence — a blinded, multicenter COPD trial — used inhaled hydrogen in hospitalized patients and reported faster symptom-score improvement on breathlessness and cough, with no significant difference in pulmonary function measures. The preclinical and review literature describes hydrogen lowering airway inflammation and oxidative stress markers in animal models, with a 2026 review reinforcing that pattern in COPD from three included studies. The safety data reported so far has been reassuring, the research volume is growing, and the mechanism is the same selective-antioxidant hypothesis proposed in 2007. What the studies don't do is show that drinking hydrogen water does anything for anyone's lungs — and any source telling you otherwise is getting ahead of the evidence. Hydrogen has a place on the respiratory research radar. Not as a miracle. As an actively investigated area worth watching.

The broader body of molecular hydrogen research — more than 2,000 published studies and counting — is the best place to keep reading if the lung work caught your attention.

References

Ohsawa I, et al. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nature Medicine. 2007;13(6):688-694. PMID: 17486089. DOI: 10.1038/nm1577
Zheng ZG, Sun WZ, Hu JY, et al. Hydrogen/oxygen therapy for the treatment of an acute exacerbation of chronic obstructive pulmonary disease: results of a multicenter, randomized, double-blind, parallel-group controlled trial. Respiratory Research. 2021;22(1):149. PMID: 33985501. DOI: 10.1186/s12931-021-01740-w
Guan WJ, Wei CH, Chen AL, et al. Hydrogen/oxygen mixed gas inhalation improves disease severity and dyspnea in patients with Coronavirus disease 2019 in a recent multicenter, open-label clinical trial. Journal of Thoracic Disease. 2020;12(6):3448-3452. PMID: 32642277. DOI: 10.21037/jtd-2020-057
Chuang YT, Tseng C, Chen TA. A narrative review of hydrogen therapy for COPD: aging-related insights. Open Medicine (Warsaw). 2026;21(1):20261438. PMID: 42164762. DOI: 10.1515/med-2026-1438
He W, Rahman MH, Bajgai J, et al. Hydrogen Gas Inhalation Alleviates Airway Inflammation and Oxidative Stress on Ovalbumin-Induced Asthmatic BALB/c Mouse Model. Antioxidants (Basel). 2024;13(11):1328. PMID: 39594470. DOI: 10.3390/antiox13111328
Ageta K, Hirayama T, Aokage T, et al. Hydrogen inhalation attenuates lung contusion after blunt chest trauma in mice. Surgery. 2023;174(2):343-349. PMID: 37210236. DOI: 10.1016/j.surg.2023.04.029
Wang Y, Han Q, Liu L, et al. Natural hydrogen gas and engineered microalgae prevent acute lung injury in sepsis. Materials Today Bio. 2024;28:101247. PMID: 39328786. DOI: 10.1016/j.mtbio.2024.101247
Liu L, Wang S, Jiang L, et al. Molecular hydrogen reduces traumatic brain injury-induced lung injury via NLRP3 inflammasome inhibition. BMC Chemistry. 2025;19(1):138. PMID: 40405232. DOI: 10.1186/s13065-025-01513-2
Jiang S, Chen H, Shen P, et al. Gasotransmitter Research Advances in Respiratory Diseases. Antioxidants & Redox Signaling. 2023;40(1-3):168-185. PMID: 37917094. DOI: 10.1089/ars.2023.0410
Johnsen HM, Hiorth M, Klaveness J. Molecular Hydrogen Therapy—A Review on Clinical Studies and Outcomes. Molecules. 2023;28(23):7785. PMID: 38067515. DOI: 10.3390/molecules28237785
Perveen I, Bukhari B, Najeeb M, et al. Hydrogen Therapy and Its Future Prospects for Ameliorating COVID-19: Clinical Applications, Efficacy, and Modality. Biomedicines. 2023;11(7):1892. PMID: 37509530. DOI: 10.3390/biomedicines11071892

Holy Hydrogen products, including the Lourdes Hydrofix Premium Edition, are not medical devices and are not intended to diagnose, treat, cure, or prevent any disease. All information on this site is provided for educational and general wellness purposes only and should not be considered medical advice. Always consult a qualified healthcare provider before beginning any new wellness practice, especially if you have a medical condition, are pregnant or nursing, or take prescription medications.

Back to blog